Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Alzheimer's Disease

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 81 articles: HTML format Text format

Single Articles

February 2010
1. KELLEY BJ , Haidar W, Boeve BF, Baker M, et al
   Alzheimer Disease-like Phenotype Associated With the c.154delA Mutation in Progranulin.
   Arch Neurol. 2010;67:171-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
2. GANGULI M , Kukull WA
   Lost in translation: epidemiology, risk, and Alzheimer disease.
   Arch Neurol. 2010;67:107-11.
   PubMed     Text format     Related articles   
   
   
   
3. WANG L , Harms MP, Staggs JM, Xiong C, et al
   Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease.
   Arch Neurol. 2010;67:99-106.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. THAMBISETTY M , Beason-Held L, An Y, Kraut MA, et al
   APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
   Arch Neurol. 2010;67:93-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GEDA YE , Roberts RO, Knopman DS, Christianson TJ, et al
   Physical exercise, aging, and mild cognitive impairment: a population-based study.
   Arch Neurol. 2010;67:80-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. BAKER LD , Frank LL, Foster-Schubert K, Green PS, et al
   Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
   Arch Neurol. 2010;67:71-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. CAIRNS NJ , Ikonomovic MD, Benzinger T, Storandt M, et al
   Absence of Pittsburgh Compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.
   Arch Neurol. 2009;66:1557-62.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. VILLEMAGNE VL , Ataka S, Mizuno T, Brooks WS, et al
   High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
   Arch Neurol. 2009;66:1537-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. LIPPA CF , Rosso AL, Stutzbach LD, Neumann M, et al
   Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome.
   Arch Neurol. 2009;66:1483-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MORRIS JC , Roe CM, Grant EA, Head D, et al
    Pittsburgh Compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
    Arch Neurol. 2009;66:1469-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. CAIRNS NJ , Ikonomovic MD, Benzinger T, Storandt M, et al
    Absence of PIttsburgh Compound B Detection of CerebralAmyloid Beta in a Patient With Clinical, Cognitive, and Cerebrospinal FluidMarkers of Alzheimer Disease.
    Arch Neurol. 2009;66:1557-1562.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
12. HAYDEN KM , Zandi PP, West NA, Tschanz JT, et al
    Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
    Arch Neurol. 2009;66:1378-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BOYLE PA , Buchman AS, Wilson RS, Leurgans SE, et al
    Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons.
    Arch Neurol. 2009;66:1339-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. NYGAARD HB , Strittmatter SM
    Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
    Arch Neurol. 2009;66:1325-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
15. CELLINI E , Tedde A, Bagnoli S, Pradella S, et al
    Implication of sex and SORL1 variants in italian patients with Alzheimer disease.
    Arch Neurol. 2009;66:1260-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. JOHNSON DK , Storandt M, Morris JC, Galvin JE, et al
    Longitudinal study of the transition from healthy aging to Alzheimer disease.
    Arch Neurol. 2009;66:1254-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
17. PORTET F , Scarmeas N, Cosentino S, Helzner EP, et al
    Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.
    Arch Neurol. 2009;66:1120-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
18. SCARMEAS N , Honig LS, Choi H, Cantero J, et al
    Seizures in Alzheimer disease: who, when, and how common?
    Arch Neurol. 2009;66:992-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
19. CHOW TW , Binns MA, Cummings JL, Lam I, et al
    Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type.
    Arch Neurol. 2009;66:888-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. RICHARDSON JR , Shalat SL, Buckley B, Winnik B, et al
    Elevated serum pesticide levels and risk of Parkinson disease.
    Arch Neurol. 2009;66:870-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
21. WILSON RS , Aggarwal NT, Barnes LL, Bienias JL, et al
    Biracial population study of mortality in mild cognitive impairment and Alzheimer disease.
    Arch Neurol. 2009;66:767-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. WILLIAMS MM , Roe CM, Morris JC
    Stability of the Clinical Dementia Rating, 1979-2007.
    Arch Neurol. 2009;66:773-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
23. IKONOMOVIC MD , Wecker L, Abrahamson EE, Wuu J, et al
    Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Arch Neurol. 2009;66:646-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SNIDER BJ , Fagan AM, Roe C, Shah AR, et al
    Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.
    Arch Neurol. 2009;66:638-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. PETRIE EC , Cross DJ, Galasko D, Schellenberg GD, et al
    Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
    Arch Neurol. 2009;66:632-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. KAYE J
    Ginkgo biloba prevention trials: more than an ounce of prevention learned.
    Arch Neurol. 2009;66:652-4.
    PubMed     Text format     Related articles   
    
    
    
27. DONG Y , Zhang G, Zhang B, Moir RD, et al
    The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels.
    Arch Neurol. 2009;66:620-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
28. VISWANATHAN A
    High-dose B vitamin supplementation as a disease-modifying therapy in Alzheimer disease.
    Arch Neurol. 2009;66:520-2.
    PubMed     Text format     Related articles   
    
    
    
29. MA QL , Galasko DR, Ringman JM, Vinters HV, et al
    Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
    Arch Neurol. 2009;66:448-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. SOLFRIZZI V , Frisardi V, Capurso C, D'Introno A, et al
    Moderate alcohol consumption, apolipoprotein E, and neuroprotection.
    Arch Neurol. 2009;66:541-2.
    PubMed     Text format     Related articles   
    
    
    
31. BREGMAN N , Karni A, Korczyn AD
    Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia?
    Arch Neurol. 2009;66:539-40.
    PubMed     Text format     Related articles   
    
    
    
32. MAYEUX R , St George-Hyslop P
    Brain traffic: subcellular transport of the amyloid precursor protein.
    Arch Neurol. 2009;66:433-4.
    PubMed     Text format     Related articles   
    
    
    March 2009
33. TAPIOLA T , Alafuzoff I, Herukka SK, Parkkinen L, et al
    Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Arch Neurol. 2009;66:382-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. BRAR S , Henderson D, Schenck J, Zimmerman EA, et al
    Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.
    Arch Neurol. 2009;66:371-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. QIN W , Haroutunian V, Katsel P, Cardozo CP, et al
    PGC-1{alpha} expression decreases in the Alzheimer disease brain as a function of dementia.
    Arch Neurol. 2009;66:352-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. HELZNER EP , Luchsinger JA, Scarmeas N, Cosentino S, et al
    Contribution of vascular risk factors to the progression in Alzheimer disease.
    Arch Neurol. 2009;66:343-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. CRAFT S
    The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.
    Arch Neurol. 2009;66:300-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. FITZPATRICK AL , Kuller LH, Lopez OL, Diehr P, et al
    Midlife and late-life obesity and the risk of dementia: cardiovascular health study.
    Arch Neurol. 2009;66:336-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
39. PALOP JJ , Mucke L
    Epilepsy and Cognitive Impairments in Alzheimer Disease.
    Arch Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SCHJEIDE BM , Hooli B, Parkinson M, Hogan MF, et al
    GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results.
    Arch Neurol. 2009;66:250-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. XIA W , Yang T, Shankar G, Smith IM, et al
    A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Arch Neurol. 2009;66:190-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. SCARMEAS N , Stern Y, Mayeux R, Manly JJ, et al
    Mediterranean diet and mild cognitive impairment.
    Arch Neurol. 2009;66:216-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. JOSEPHS KA , Ahlskog JE, Parisi JE, Boeve BF, et al
    Rapidly progressive neurodegenerative dementias.
    Arch Neurol. 2009;66:201-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
44. KILE SJ , Ellis WG, Olichney JM, Farias S, et al
    Alzheimer abnormalities of the amygdala with Kluver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease.
    Arch Neurol. 2009;66:125-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. WILEY CA , Lopresti BJ, Venneti S, Price J, et al
    Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.
    Arch Neurol. 2009;66:60-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
46. BRITSCHGI M , Wyss-Coray T
    Blood Protein Signature for the Early Diagnosis of Alzheimer Disease.
    Arch Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. T CUENCO K , Lunetta KL, Baldwin CT, McKee AC, et al
    Association of Distinct Variants in SORL1 With Cerebrovascular and Neurodegenerative Changes Related to Alzheimer Disease.
    Arch Neurol. 2008;65:1640-1648.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. NERVI A , Reitz C, Tang MX, Santana V, et al
    Comparison of clinical manifestations in Alzheimer disease and dementia with lewy bodies.
    Arch Neurol. 2008;65:1634-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
49. LEE JH , Cheng R, Graff-Radford N, Foroud T, et al
    Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.
    Arch Neurol. 2008;65:1518-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. ROE CM , Mintun MA, D'Angelo G, Xiong C, et al
    Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.
    Arch Neurol. 2008;65:1467-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KELLEY BJ , Boeve BF, Josephs KA
    Young-onset dementia: demographic and etiologic characteristics of 235 patients.
    Arch Neurol. 2008;65:1502-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
52. SCHAFFER BA , Bertram L, Miller BL, Mullin K, et al
    Association of GSK3B with Alzheimer disease and frontotemporal dementia.
    Arch Neurol. 2008;65:1368-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. EVATT ML , Delong MR, Khazai N, Rosen A, et al
    Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.
    Arch Neurol. 2008;65:1348-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. KLUNK WE
    Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.
    Arch Neurol. 2008;65:1281-3.
    PubMed     Text format     Related articles   
    
    
    
55. LEINONEN V , Alafuzoff I, Aalto S, Suotunen T, et al
    Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Arch Neurol. 2008;65:1304-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
56. HAROUTUNIAN V , Schnaider-Beeri M, Schmeidler J, Wysocki M, et al
    Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.
    Arch Neurol. 2008;65:1211-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. BRICKMAN AM , Honig LS, Scarmeas N, Tatarina O, et al
    Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease.
    Arch Neurol. 2008;65:1202-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
58. ZETTERBERG H , Andreasson U, Hansson O, Wu G, et al
    Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Arch Neurol. 2008;65:1102-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. O'BRYANT SE , Waring SC, Cullum CM, Hall J, et al
    Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
    Arch Neurol. 2008;65:1091-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. FLEISHER AS , Raman R, Siemers ER, Becerra L, et al
    Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.
    Arch Neurol. 2008;65:1031-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
61. ROZZINI L , Vicini Chilovi B, Trabucchi M, Padovani A, et al
    Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease.
    Arch Neurol. 2008;65:993-4.
    PubMed     Text format     Related articles   
    
    
    
62. HARRISON J
    Notice of failure to disclose financial interest: "A neuropsychological test battery for use in Alzheimer disease clinical trials" (Arch Neurol. 2007;64[9]:1323-1329).
    Arch Neurol. 2008;65:992.
    PubMed     Text format     Related articles   
    
    
    
63. STEINERMAN JR , Irizarry M, Scarmeas N, Raju S, et al
    Distinct Pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.
    Arch Neurol. 2008;65:906-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SEPHTON CF , Yu G
    Abeta predictor of Alzheimer disease symptoms.
    Arch Neurol. 2008;65:875-6.
    PubMed     Text format     Related articles   
    
    
    June 2008
65. PETTERSEN JA , Sathiyamoorthy G, Gao FQ, Szilagyi G, et al
    Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook Dementia Study.
    Arch Neurol. 2008;65:790-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. LOCASCIO JJ , Fukumoto H, Yap L, Bottiglieri T, et al
    Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.
    Arch Neurol. 2008;65:776-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
67. 
    Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib.
    Arch Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. KUCZYNSKI B , Reed B, Mungas D, Weiner M, et al
    Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
    Arch Neurol. 2008;65:650-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
69. BASUN H , Bogdanovic N, Ingelsson M, Almkvist O, et al
    Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease.
    Arch Neurol. 2008;65:499-505.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. REMES AM , Laru L, Tuominen H, Aalto S, et al
    Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.
    Arch Neurol. 2008;65:540-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. BIRD TD , Lipe HP, Steinbart EJ
    Geriatric neurogenetics: oxymoron or reality?
    Arch Neurol. 2008;65:537-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
72. JAYADEV S , Steinbart EJ, Chi YY, Kukull WA, et al
    Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease.
    Arch Neurol. 2008;65:373-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. WARING SC , Rosenberg RN
    Genome-wide association studies in Alzheimer disease.
    Arch Neurol. 2008;65:329-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. SMALL SA
    Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease.
    Arch Neurol. 2008;65:323-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. RINGMAN JM , Rao PN, Lu PH, Cederbaum S, et al
    Mosaicism for trisomy 21 in a patient with young-onset dementia: a case report and brief literature review.
    Arch Neurol. 2008;65:412-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
76. SUNDELOF J , Giedraitis V, Irizarry MC, Sundstrom J, et al
    Plasma {beta} Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study.
    Arch Neurol. 2008;65:256-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. ROGALSKI E , Johnson N, Weintraub S, Mesulam M, et al
    Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives.
    Arch Neurol. 2008;65:244-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
78. FOTENOS AF , Mintun MA, Snyder AZ, Morris JC, et al
    Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.
    Arch Neurol. 2008;65:113-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. ROE CM , Xiong C, Grant E, Miller JP, et al
    Education and reported onset of symptoms among individuals with Alzheimer disease.
    Arch Neurol. 2008;65:108-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. IRIE F , Fitzpatrick AL, Lopez OL, Kuller LH, et al
    Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE {varepsilon}4: The Cardiovascular Health Study Cognition Study.
    Arch Neurol. 2008;65:89-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2007
81. HINERFELD DA , Moonis M, Swearer JM, Baker SP, et al
    Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects.
    Arch Neurol. 2007;64:1672-3.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: